VUCERTA
DEAD

Serial Number

79439548

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VUCERTA Trademark

Serial Number: 79439548 • Registration: 8268706

VUCERTA is a trademark filed by NOVARTIS AG on October 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 15, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Cancellation Date

May 29, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Medical apparatus for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases, and dermatological conditions

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 11, 2026 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 11, 2026 DETH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2026 CNSA
REFUSAL PROCESSED BY IB
Feb 26, 2026 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 4, 2026 RFRR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 13, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 13, 2026 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 6, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 29, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 29, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 18, 2025 REPR